15 Aug 2017
Genetic forces drive a sizable portion of Alzheimers disease, yet only a fraction of cases thus far are explained by known mutations. A handful of recent papers used genomic sequencing to fish out new variants that, while exceedingly rare, pack a wallop in those who carry them. In the July 24 JAMA Neurology, researchers led by Margaret Pericak-Vance at the University of Miami in Florida reported that mutations in four endolysosomal transport genes boosted risk of early onset AD (EOAD). A few weeks earlier, a large collaboration of French researchers reported rare new TREM2, ABCA7, and SORL1 variants in Neurobiology of Aging, while scientists led by Henne Holstege at VU University Medical Center in Amsterdam characterized the pathogenicity of SORL1 variants and even proposed classifying this endosomal sorting protein as the fourth autosomal-dominant AD gene. A team led by Dominique Campion at University of Rouen, France, dug deep into the well-trodden territory of the three autosomal-dominant genesAPP, PS1, and PS2and uncovered de novo pathogenic variants that cropped up in people with no family history of AD. Last but not least, Anne Rovelet-Lecrux, also at Rouen, linked a duplication in the tau gene to people with an AD diagnosis who lacked Aplaques.
Together, the studies move the field a step closer to filling in the missing genetic influence on AD, and could provide new targets for therapeutic strategies, commented Liana Apostolova at the University of Indiana in Bloomington. There are more genetic risk factors in hiding that have yet to be discovered, and these studies suggest were on the right track, she toldAlzforum.
In the JAMA Neurology study, first author Brian Kunkle and colleagues report on their search for rare variants with large effects on AD risk. Reasoning that people with EOAD are likely carriers of damaging genetic mutations, they conducted whole-exome sequencing in 51 non-Hispanic white EOAD patients, plus 53 people from 19 Caribbean Hispanic families with EOAD; all had tested negative for known causal mutations in APP, PS1, and PS2. The scientists combed the exomes for variants predicted to have damaging effects, then attempted to validate each variants association with AD using exome genotyping data from a separate cohort of 1,500 EOAD patients, 7,000 LOAD patients, and 7,000 controls. Developed by the Alzheimers Disease Genetics Consortium (ADGC), the exome chip used to genotype this separate cohort contains more than 200,000 variants, most of which are functional, rare, single nucleotidemutations.
In their original sequencing cohort, the researchers identified mutations in known or suspected EOAD genes, including SORL1, PS1, PS2, TREM2, and MAPT. Some were known; others were new variants in genes previously tied to LOAD, including HLA-DRB1, ABCA7, and RIN3. Suspicious mutations also cropped up in genes without an AD record. A missense mutation in TCIRG1, present in a non-Hispanic white person with EOAD and segregating with EOAD in three Hispanic families, was twice as frequent in EOAD than in controls in the validation cohort. Deleterious mutations in PSD2 appeared in multiple unrelated cases in the sequencing cohort, and associated with EOAD in the validation cohort, at least when considered in the aggregate. Mutations in RIN3 and RUFY1 appeared in the discovery cohort, but their EOAD association in the validation group was nominal. Importantly, all four genes function in different parts of the endolysosomal transport pathway, which is essential for clearing cellular debris and unwanted proteins, includingA.
The researchers found additional rare mutations in EOAD patients, but these were not on the exome chip used for the validation cohort. For example, of 151 potentially damaging variants that appeared in the original exome sequencing cohort, only 43 were included on the exomechip.
While this filtering process allows researchers to test whether a variant is truly linked to disease, it also precludes consideration of totally new, potentially damaging mutations, said Holstege. The mutations that are most damaging are also the most rare, Holstege told Alzforum. If you filter them out in this way, you quench yoursignal.
Holstege took a different tack to find and classify rare SORL1 variants. Rather than filtering out undocumented variants, Holstege and colleagues made them their bread and butter. In the May 24 European Journal of Human Genetics, they reported 115 SORL1 variants from the exomes of a Dutch cohort of 640 AD cases and 1,268 controls. Fifteen of these variants were common, and not associated with AD. The other 100 were rare, occurring in less than 0.01 percent of the population. Of those, 19 were predicted to be strongly damaging, based on high scores on CADD, an algorithm that considers more than 100 variant characteristics to predict how likely a given mutation is to alter protein function orexpression.
Strikingly, 16 of these suspicious variants only appeared in a single person within the entire cohort, and 14 of those had AD. None of the variants were included in prior exome genotyping studies, so the researchers could not draw upon past data to validate whether they truly associated with the disease. Instead, the researchers developed a pathogenicity scale. Weaving in data from more than 3,000 exomes sequenced separately, the researchers classified a total 181 SORL1 variants based on their combined CADD scores and rarity. They categorized those that had high CADD scores and were very rare as pathogenic. Estimated pathogenicity decreased from likely pathogenic to uncertain to likely benign to benign as variants became less damaging and morecommon.
The scientists found that a combination of high CADD scores and extremely low allele frequency selected out those SORL1 variants that occurred much more often in cases than in controls. The 13 variants with the highest pathogenicity resulted in truncations of SORL1, and occurred only in AD cases. The researchers predicted they would cause dominantly inherited AD, though none have yet been traced in familypedigrees.
Holstege and colleagues proposed that SORL1 take a spot alongside PS1, PS2, and APP as an autosomal-dominant AD gene. Pathogenic SORL1 mutations occurred in 2 percent of the AD cases in this study, placing them at a higher frequency than other ADAD genes. Like PS1, PS2, and APP, SORL1 protein strongly influences A, as it protects APP from amyloidogenic processing and ushers A to lysosomes for disposal (see Sep 2007 news; Feb 2014 news).
Classifying SORL1 as an ADAD gene would raise new questions. How to provide genetic counseling to affected families? Should mutation carriers be eligible to join the Dominantly Inherited Alzheimers Network (DIAN)? Clinical-grade genetic tests for SORL1 variants would be needed, a challenge developers may postpone until further data has confirmed the mutations are pathogenic, commented Apostolova. She added that while Holsteges pathogenicity scale is an exciting tool that should be used in future studies, validation of each mutation in other cohorts, as well as functional evidence in animal and cell culture studies, should be required to elevate SORL1 to ADAD status. Rovelet-Lecrux agreed that designating SORL1 an ADAD gene will have to await discovery of multigenerational families in which SORL1 segregates with disease in an autosomal-dominant pattern. Until we accumulate more genetic evidence, we cannot tell SORL1 mutation carriers how likely they are to develop disease, shesaid.
A new study led by Rouens Campion and co-authored by Rovelet-Lecrux further supports pathogenicity of SORL1 variants, even if it does not provide evidence of multigenerational segregation. As reported July 13 in the Neurobiology of Aging, the researchers detected SORL1 missense and protein-truncating variants that associated strongly with early onset disease by doing whole-exome and genome sequencing of a French cohort of 852 EOAD, 927 LOAD, and 1,273 control cases. All but one of 13 protein-truncating variants occurred only in EOAD cases, and eight of 10 cases with available family information had a history of the disease. Besides SORL1, TREM2 and ABCA7 also harbored potentially damaging EOAD-associated variants in this sample. The researchers estimated that variants in these three genes accounted for 1.42, 1.17, and 1.33 percent of EOAD heritability, respectively. By comparison, ApoE4 accounted for 9.12percent.
New Finds in Old GenesWhile many pathogenic mutations in PS1, PS2, and APP have been traced in family pedigrees, additional rare variants in these established ADAD genes may yet be discovered. In search of them, researchers led by Rouens Campion sequenced these genes in 129 sporadic cases of early onset AD, as well as in 53 affected families. Published March 28 in PLOS Medicine, the findings included data from participants who joined the ongoing French study after 2012, when the researchers had published a similar analysis (Wallon et al., 2012).In all, first author Hlne-Marie Lanoisele and colleagues identified 44 PS1, two PS2, and 20 APP mutations, as well as five APP duplications; 12 of the PS1 and one PS2 mutation had not been reportedpreviously.
The most striking finding was the existence of de novo mutations in PS1. Indeed, seven of 12 new mutations occurred in sporadic cases of EOAD. In three of these mutations, the researchers were able to confirm that the carriers parents did not carry the new mutation. Rovelet-Lecrux, a co-author on the paper, said that the prevalence of de novo mutations in ADAD genes is likely underestimated, because routine genetic screening for these mutations is done only in familial AD cases. The de novo find underscores the importance of checking for pathogenic mutations even in patients without a family history of AD, especially people with an early age at onset, Holstege commented. Similar to the situation with rare SORL1 variants, researchers will need to decide how to categorize carriers of new and de novo mutations in established ADAD genes, shesaid.
Finally, results from a slightly older study led by Rovelet-Lecrux pose a different kind of classification conundrum. The authors deployed whole-exome sequencing to hunt specifically for copy number variations (CNVs) such as duplications and deletions in 335 genes predicted to influence A processing, clearance, or aggregation. The researchers found CNVs in 30 out of 522 people with EOAD, but only 18 out of 584 controls. Most of these CNVs occurred in a single person in the cohort, and they included novel deletions in the PS1, ABCA7, and SLC30A3 genes previously tied toAD.
A surprising finding reared its head in four AD cases, who all had a duplicationin a region of chromosome 17 including MAPT, the gene encoding none other than tau. The duplication appeared in two sporadic cases of EOAD and two with a family history. DNA available from one of those families confirmed that the duplication segregated with EOAD. Even though these four carriers had symptoms consistent with AD, the three who underwent amyloid-PET imaging had negative scans, to Rovelet-Lecruxs surprise. All four duplication carriers had abnormal levels of CSF p-tau and tau, and three of them also had abnormal concentrations of A42. The researchers also found nearly double the amount of tau mRNA in the blood of carriers than incontrols.
Together, the findings suggest that despite the lack of A plaques visible on PET, carriers of a tau duplication have a clinical disorder markedly similar to AD. The abnormality of CSF A42 in three of the duplication carriers suggests that they could have accumulated A just below the level of PET detection, a sub-threshold aggregation the researchers speculated could even be somehow caused by elevatedtau.
Do these tau duplication carriers have AD? Not if you consider A accumulation as a defining feature of the disease, said Apostolova. Indeed, in the paper, the researchers defined their disease as a tau-related dementia, proposing that it could account for a significant proportion of early onset dementia cases with no genetic explanation. While some researchers view A as a mere forerunner to the more destructive tau pathology, which they consider the main event in AD, Rovelet-Lecrux shied away from separating A from AD, saying that AD is ultimately diagnosed via its neuropathological hallmarks of A plaques and tau tangles. She believes it will be important to screen EOAD patients without A plaques for tau pathology, especially in the future once both A- or tau-targeted therapies exist.JessicaShugart
Read the original post:
The Search for the Missing AD Heritability Turns Up New Rare Variants - Alzforum
- Avera Medical Minute AMcK: Researching the human genome - April 10th, 2014 [April 10th, 2014]
- Artificial Reproductive Technology: Constructing a Dystopia - April 10th, 2014 [April 10th, 2014]
- Human genetics - Wikipedia, the free encyclopedia - April 10th, 2014 [April 10th, 2014]
- Wellcome Trust Centre for Human Genetics - Video - April 10th, 2014 [April 10th, 2014]
- Human Genetics Biology Project - Video - April 10th, 2014 [April 10th, 2014]
- Dame Bridget Ogilvie: Women in Science - Video - April 15th, 2014 [April 15th, 2014]
- Human Genetics | Buzzle.com - April 16th, 2014 [April 16th, 2014]
- Refining language for chromosomes - April 17th, 2014 [April 17th, 2014]
- Refining the language for chromosomes - April 17th, 2014 [April 17th, 2014]
- CU system resets health care with $63M personalized medicine division - April 21st, 2014 [April 21st, 2014]
- Human Genetics and Personalized Medicine, Dr. David Cox - Video - April 21st, 2014 [April 21st, 2014]
- Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses - April 22nd, 2014 [April 22nd, 2014]
- Software Identifies Gene Mutations in 3 Undiagnosed Children - April 22nd, 2014 [April 22nd, 2014]
- International collaboration unravels novel mechanism for neurological disorder - April 25th, 2014 [April 25th, 2014]
- Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism ... - April 25th, 2014 [April 25th, 2014]
- Dive into Human Genetics - Video - April 26th, 2014 [April 26th, 2014]
- A new syndrome caused by mutations in AHDC1 - May 2nd, 2014 [May 2nd, 2014]
- Exploring genetics behind Alzheimer's resiliency - May 3rd, 2014 [May 3rd, 2014]
- Human genetics - An Introduction to Genetic Analysis ... - May 4th, 2014 [May 4th, 2014]
- Human Genetics - Estrella Mountain Community College - May 5th, 2014 [May 5th, 2014]
- What Is Human Genetics: How Important Is It To Science Today? - May 9th, 2014 [May 9th, 2014]
- Human Genetics Project - Video - May 9th, 2014 [May 9th, 2014]
- Journal of Human Genetics - Nature - May 16th, 2014 [May 16th, 2014]
- CSHL Keynote: Dr. Peter Donnelly, Wellcome Trust Centre for Human Genetics - Video - May 16th, 2014 [May 16th, 2014]
- New genetic sequencing methods mean quicker, cheaper, and accurate embryo screening - May 31st, 2014 [May 31st, 2014]
- Researchers take a major step towards better diagnosis and treatment of osteoporosis - May 31st, 2014 [May 31st, 2014]
- Poor coverage of specific gene sets in exome sequencing gives cause for concern - June 2nd, 2014 [June 2nd, 2014]
- Osteoporosis: Genetic researchers take major step towards better diagnosis, treatment - June 2nd, 2014 [June 2nd, 2014]
- Deletions and duplications in the exome can help pinpoint cause of unexplained genetic diseases - June 2nd, 2014 [June 2nd, 2014]
- New genes involved in food preferences will revolutionize diets and improve health - June 2nd, 2014 [June 2nd, 2014]
- ESHG14 Update on Ion PII and Ion Chef from Andy Felton - Video - June 4th, 2014 [June 4th, 2014]
- Ancient Human-Chimp Link Pushed Back Millions of Years - June 22nd, 2014 [June 22nd, 2014]
- Chinakov Vs. The Hidden Ep 4: Lets Play Some Xbox - Video - June 22nd, 2014 [June 22nd, 2014]
- Reaction to the $1,000 Genome - June 26th, 2014 [June 26th, 2014]
- Tragicom Studios Movie Explores Link between the Technology Industry and the Rise in Autism with Futuristic Eugenics ... - June 26th, 2014 [June 26th, 2014]
- 09 Prof. Richard Gold, Esq. - Video - June 29th, 2014 [June 29th, 2014]
- John Maunsell Takes Helm of Neuroscience Institute at University of Chicago - July 2nd, 2014 [July 2nd, 2014]
- Illumina Expands in Europe on 3 NIPT Deals - Analyst Blog - July 2nd, 2014 [July 2nd, 2014]
- GHOST STORY (The Hidden) - Video - July 6th, 2014 [July 6th, 2014]
- HOW TO MOONSHINE (The Hidden) - Video - July 9th, 2014 [July 9th, 2014]
- Will Genomics Soon Explain the Human Brain Gain? - July 11th, 2014 [July 11th, 2014]
- WIGGLE WIGGLE WIGGLE (The Hidden) - Video - July 11th, 2014 [July 11th, 2014]
- The Hidden Source : Beta - 1 V.S.1 me Brah! - w/ Friend (Short footage) - Video - July 18th, 2014 [July 18th, 2014]
- Three parent babies banned from knowing 'second mothers' - July 23rd, 2014 [July 23rd, 2014]
- 2014 ASHG Annual Meeting Schedule Overview - Video - July 24th, 2014 [July 24th, 2014]
- Pinpointing genetic links to schizophrenia may open doors to better treatment - July 26th, 2014 [July 26th, 2014]
- Factoring in Mendel and Human Genetics - Video - July 27th, 2014 [July 27th, 2014]
- University of Maryland Schools of Dentistry and Medicine receive NIH grant - July 29th, 2014 [July 29th, 2014]
- Mosaicism: Study clarifies parents as source of new disease mutations - July 31st, 2014 [July 31st, 2014]
- Human Genetics and the Image of God - Video - August 7th, 2014 [August 7th, 2014]
- Bigfoot and yeti, as elusive as ever - August 8th, 2014 [August 8th, 2014]
- Fruit Flies Used To Unlock Mysteries Of Human Diabetes - August 11th, 2014 [August 11th, 2014]
- 23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease - August 12th, 2014 [August 12th, 2014]
- Penn's Basser Research Center for BRCA Names BRCA1 Founder Mary-Claire King Winner of the 2014 Basser Global Prize - August 12th, 2014 [August 12th, 2014]
- Announcing Speakers at BioConference Live Genetics and Genomics 2014 - August 19th, 2014 [August 19th, 2014]
- MARC travel awards announced for: American Society of Human Genetics 2014 Annual Meeting - August 28th, 2014 [August 28th, 2014]
- Human Genetics - The Complexity of Living Cells Debunks Evolution. - Video - September 1st, 2014 [September 1st, 2014]
- ASHG and NHGRI award first genetics and education fellowship - September 2nd, 2014 [September 2nd, 2014]
- ASHG and NHGRI award genetics and public policy fellowship - September 2nd, 2014 [September 2nd, 2014]
- Mapping the DNA Sequence of Ashkenazi Jews - September 10th, 2014 [September 10th, 2014]
- Google Continues To Build Upon Its Life Sciences Ecosystem - September 12th, 2014 [September 12th, 2014]
- Scientists discover genetic link to autism, developmental disorders - September 15th, 2014 [September 15th, 2014]
- Scientists discover possible genetic link to autism, developmental disorders - September 15th, 2014 [September 15th, 2014]
- Human Genetics DNA and RNA.mp4 - Video - September 18th, 2014 [September 18th, 2014]
- Dogs, humans attack cancer together - September 19th, 2014 [September 19th, 2014]
- Cancer treatment for dogs could one day save humans - September 19th, 2014 [September 19th, 2014]
- Synthetic sperm protein raises the chance for successful in vitro fertilization - September 30th, 2014 [September 30th, 2014]
- Gene Interacts with Stress and Leads to Heart Disease in Some People - October 1st, 2014 [October 1st, 2014]
- ASHG Launches Scientific EventPilot Meeting App with 3,500 Offline Abstracts for the Largest Human Genetics Meeting ... - October 1st, 2014 [October 1st, 2014]
- Human genetics of malaria has uncovered some new clues about susceptibility to severe malaria - Video - October 4th, 2014 [October 4th, 2014]
- How Iceland's Genealogy Obsession Leads to Scientific Breakthroughs - October 8th, 2014 [October 8th, 2014]
- Dartmouth Researchers Develop Reproducibility Score for SNPs Associated with Human Disease in GWAS - October 8th, 2014 [October 8th, 2014]
- Researchers develop reproducibility score for SNPs associated with human disease in GWAS - October 8th, 2014 [October 8th, 2014]
- Moore Foundation Selects Matthew Stephens for Data-Driven-Discovery Grant - October 9th, 2014 [October 9th, 2014]
- Reproducibility score for SNPs associated with human disease in GWAS - October 9th, 2014 [October 9th, 2014]
- Multiple neurodevelopmental disorders have a common molecular cause - October 9th, 2014 [October 9th, 2014]
- Human Genetics Molecular Biology of Gene - Video - October 10th, 2014 [October 10th, 2014]
- Human genetics : gel electrophoresis - Video - October 11th, 2014 [October 11th, 2014]
- Giant gene banks take on disease - October 14th, 2014 [October 14th, 2014]
- Gene duplications associated with autism evolved recently in human history - October 19th, 2014 [October 19th, 2014]